Psychostimulant-related deaths among former inmates
- PMID: 22134174
- PMCID: PMC3883279
- DOI: 10.1097/ADM.0b013e318239c30a
Psychostimulant-related deaths among former inmates
Abstract
Objectives: Psychostimulants are highly addictive and their use is increasing. Little is known about psychostimulant-related deaths. This study identified characteristics, risk factors, and contributing substances reported upon death among former prison inmates who died from a psychostimulant-related death.
Methods: This retrospective cohort study of released inmates from 1999 to 2003 (N = 30,237) linked data from the Washington State Department of Corrections with the National Death Index. We examined characteristics of individuals who died with psychostimulants listed among their causes of death. These were categorized into 3 groups: (1) noncocaine psychostimulants, (2) cocaine only, and (3) all psychostimulants. Cox proportional hazards regression determined risk factors for death in each group, and the risk of death in the first 2 weeks after release from prison
Results: Of the 443 inmates who died, 25 (6%) had noncocaine psychostimulants listed among their causes of death. Six of these 25 deaths had both noncocaine psychostimulants and cocaine listed among their causes-of-death. Most of the former inmates who died with noncocaine psychostimulants were male (n = 21, 84%) and non-Hispanic white (88%, n = 22). Cocaine only was listed among the causes-of-death for 49 former inmates; most were male (n = 35, 71%) and non-Hispanic white (n = 27, 55%). Longer length of incarceration was associated with a reduced risk of death from any psychostimulant use (hazard ratio = 0.76, confidence interval = 0.63-0.920 for each additional year of incarceration) and from use of noncocaine psychostimulants (hazard ratio = 0.42, 95% CI = 0.22-0.80). Risk of death was highest during the first 2 weeks postrelease for cocaine only-related deaths (incidence mortality ratio = 1224.0, confidence interval = 583-1865).
Conclusions: Former prisoners have a significant risk of death from psychostimulants, especially within the first 2 weeks postrelease.
Conflict of interest statement
Conflict of Interest: None
Similar articles
-
Release from prison--a high risk of death for former inmates.N Engl J Med. 2007 Jan 11;356(2):157-65. doi: 10.1056/NEJMsa064115. N Engl J Med. 2007. PMID: 17215533 Free PMC article.
-
Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009.Ann Intern Med. 2013 Nov 5;159(9):592-600. doi: 10.7326/0003-4819-159-9-201311050-00005. Ann Intern Med. 2013. PMID: 24189594 Free PMC article.
-
Risk factors for all-cause, overdose and early deaths after release from prison in Washington state.Drug Alcohol Depend. 2011 Aug 1;117(1):1-6. doi: 10.1016/j.drugalcdep.2010.11.029. Epub 2011 Feb 3. Drug Alcohol Depend. 2011. PMID: 21295414
-
Understanding drug-related mortality in released prisoners: a review of national coronial records.BMC Public Health. 2012 Apr 4;12:270. doi: 10.1186/1471-2458-12-270. BMC Public Health. 2012. PMID: 22475069 Free PMC article. Review.
-
Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis.Psychopharmacology (Berl). 2020 Aug;237(8):2233-2255. doi: 10.1007/s00213-020-05563-3. Epub 2020 Jun 29. Psychopharmacology (Berl). 2020. PMID: 32601988
Cited by
-
Association of Opioid and Stimulant Use Disorder Diagnoses With Fatal and Nonfatal Overdose Among People With a History of Incarceration.JAMA Netw Open. 2022 Nov 1;5(11):e2243653. doi: 10.1001/jamanetworkopen.2022.43653. JAMA Netw Open. 2022. PMID: 36416821 Free PMC article.
-
The predictive validity of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) for moderate- to high-risk cannabis, methamphetamine and opioid use after release from prison.Addiction. 2023 Jun;118(6):1107-1115. doi: 10.1111/add.16138. Epub 2023 Feb 6. Addiction. 2023. PMID: 36680769 Free PMC article.
-
Record linkage studies of drug-related deaths among adults who were released from prison to the community: a scoping review.BMC Public Health. 2023 May 5;23(1):826. doi: 10.1186/s12889-023-15673-0. BMC Public Health. 2023. PMID: 37147595 Free PMC article.
-
Substance use disorders, psychiatric disorders, and mortality after release from prison: a nationwide longitudinal cohort study.Lancet Psychiatry. 2015 May;2(5):422-430. doi: 10.1016/S2215-0366(15)00088-7. Epub 2015 Apr 28. Lancet Psychiatry. 2015. PMID: 26360286 Free PMC article.
References
-
- HSA Treatment Episode Data Sets (TEDS) 2007 Oct; http://www.oas.samhsa.gov.
-
- Alaraj A, Wallace A, Mander N, Aletich V, Charbel FT, Amin-Hanjani S. Effect of acute cocaine use on vasospasm and outcome in aneurysmal subarachnoid hemorrhage. World Neurosurg. 2010 Apr;73(4):357–360. - PubMed
-
- Bashour T. Acute myocardial infarction resulting from amphetamine abuse: A spasm-thrombus interplay? Am Heart J. 1994;128:1237–1239. - PubMed
-
- Bell J, Trinh L, Butler B, Randall D, Rubin G. Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment. Addiction. 2009 Jul;104(7):1193–1200. - PubMed